BOLT
Price
$0.50
Change
-$0.04 (-7.41%)
Updated
Dec 18, 04:59 PM (EDT)
98 days until earnings call
CRIS
Price
$3.22
Change
-$0.23 (-6.67%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

BOLT vs CRIS

Header iconBOLT vs CRIS Comparison
Open Charts BOLT vs CRISBanner chart's image
Bolt Biotherapeutics
Price$0.50
Change-$0.04 (-7.41%)
Volume$5.25K
CapitalizationN/A
Curis
Price$3.22
Change-$0.23 (-6.67%)
Volume$254
CapitalizationN/A
BOLT vs CRIS Comparison Chart
Loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLT vs. CRIS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLT is a Hold and CRIS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BOLT: $0.54 vs. CRIS: $3.45)
Brand notoriety: BOLT and CRIS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLT: 47% vs. CRIS: 66%
Market capitalization -- BOLT: $20.48M vs. CRIS: $29.21M
BOLT [@Biotechnology] is valued at $20.48M. CRIS’s [@Biotechnology] market capitalization is $29.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLT’s FA Score shows that 1 FA rating(s) are green whileCRIS’s FA Score has 0 green FA rating(s).

  • BOLT’s FA Score: 1 green, 4 red.
  • CRIS’s FA Score: 0 green, 5 red.
According to our system of comparison, BOLT is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLT’s TA Score shows that 3 TA indicator(s) are bullish while CRIS’s TA Score has 2 bullish TA indicator(s).

  • BOLT’s TA Score: 3 bullish, 6 bearish.
  • CRIS’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CRIS is a better buy in the short-term than BOLT.

Price Growth

BOLT (@Biotechnology) experienced а -6.29% price change this week, while CRIS (@Biotechnology) price change was -12.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

BOLT is expected to report earnings on Mar 26, 2025.

CRIS is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRIS($29.2M) has a higher market cap than BOLT($20.5M). BOLT YTD gains are higher at: -52.214 vs. CRIS (-72.941).
BOLTCRISBOLT / CRIS
Capitalization20.5M29.2M70%
EBITDAN/AN/A-
Gain YTD-52.214-72.94172%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A2.49M-
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLTCRIS
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
BOLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

BOLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLT has been loosely correlated with ONPPF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLT jumps, then ONPPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
+3.32%
ONPPF - BOLT
62%
Loosely correlated
N/A
VRPX - BOLT
43%
Loosely correlated
-3.94%
ICCC - BOLT
28%
Poorly correlated
+3.41%
IPHYF - BOLT
27%
Poorly correlated
N/A
CRIS - BOLT
25%
Poorly correlated
-0.86%
More

CRIS and

Correlation & Price change

A.I.dvisor tells us that CRIS and INKT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRIS and INKT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-0.86%
INKT - CRIS
29%
Poorly correlated
-7.12%
BDTX - CRIS
27%
Poorly correlated
-5.30%
AVIR - CRIS
27%
Poorly correlated
+1.94%
RARE - CRIS
26%
Poorly correlated
-0.99%
RCKT - CRIS
26%
Poorly correlated
+1.36%
More